Fosun Tourism’s post-Covid holiday fizzles
The resort unit of one of China’s leading conglomerates posted modest growth in the first quarter, as its broader outlook was clouded by debt issues at its parent Key Takeaways:…
Fosun International on cusp of new ‘asset-light’ era with latest sale
The conglomerate is selling its stake in multinational insurer Ageas, extending a slimming exercise touched off by a liquidity crisis in 2022 Key Takeaways: Fosun International’s total debt-to-capitalization ratio stood…
Fosun Tourism at crossroads as parent shops its two major assets
Fosun International is reportedly looking to sell some or all of its tourism unit’s Atlantis Sanya mega-resort, as well as a stake in the unit’s Club Med resort chain Key…
Fosun Tourism embarks on new journey with departure of big-name director
Henri Giscard d’Estaing has left the board of Fosun Tourism, which is refocusing on China and Southeast Asia, to ‘devote additional time and attention’ to his role leading Club Med…
Fosun Tourism rides Club Med rebound into bumper profits
The global resort operator’s business volume rose 24% in the first half of the year, while its profit more than doubled Key Takeaways: Fosun Tourism’s business volume rose 24% in…
FAST NEWS: Business Surges at Fosun Tourism’s Core Mega-Resort
The latest: Resort operator Fosun Tourism Group (1992.HK) announced Wednesday that its core mega-resort, Atlantis Sanya, posted 159 million yuan ($23.4 million) in business volume during the 16-day period around…
Is Fosun Set to Rise Again as China Reopens?
The debt-heavy conglomerate announced a fresh $1 billion in asset sales last week, as growing signs emerge that its looming debt crisis of 2022 may be recedingKey Takeaways:Fosun International announced…
Recent Articles
RELATED ARTICLES
-
Fosun Tourism at crossroads as parent shops its two major assets
1992.HK 0656.HK
-
Fosun Tourism embarks on new journey with departure of big-name director
1992.HK
-
Fosun Tourism rides Club Med rebound into bumper profits
1992.HK
-
Debt pressures cast cloud over Fosun Pharma results
2196.HK 600196.SHG
- CHINA BULLETIN: Next Stop, Deflation
-
Tongcheng flies high on post-Covid domestic travel boom
0780.HK
-
Fosun Pharma, CanSino take different paths as Covid lift fade
2196.HK 6185.HK
